未登录

Y

Yukai He

university system of georgia

H指数:31

被引数:4,519

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CAR-Ts with moderate affinity antigen binding domain persist longer and maintain better function in tumor lesions, generating potent antitumor effects in treating solid tumors

JOURNAL OF IMMUNOLOGY

IF3.4

2025-11-010

PRE

Artificial oxyanion reservoir accelerates oriented ionic migration in MXene-based synaptic memristor for neuromorphic computing

人工氧阴离子库加速了基于MXene的仿生突触忆阻器中定向离子迁移，用于类脑计算

SURFACES AND INTERFACES

IF6.3

2025-04-010

PRE

A personal tribute to Dr. Harald zur Hausen: A distinguished scientist and caring mentor

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-10-090

OA

Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2023-06-0111

OAAI

TCR T cells overexpressing c-Jun have better functionality with improved tumor infiltration and persistence in hepatocellular carcinoma

过表达c-6月的TCR T细胞具有更好的功能，改善了肝细胞癌的肿瘤浸润和持久性

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-05-0411

OAAI

NOVEL INTERMEDIATE-AVIDITY GLYPICAN-3 SPECIFIC CARTS RESIST EXHAUSTION AND MEDIATE DURABLE ANTITUMOR EFFECTS AGAINST HUMAN HEPATOCELLULAR CARCINOMA

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-11-070

OA

The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: Moderate is better

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-10-1736

OAAI

TCR-T cells engineered to overexpress c-Jun have better functionality with improved tumor infiltration and persistence for treatment of Hepatocellular Carcinoma

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against hepatocellular carcinoma

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

OA

Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC

IF15.8

2021-12-2715

OA

Parthenolide plays a protective role in the liver of mice with metabolic dysfunction-associated fatty liver disease through the activation of the HIPPO pathway

小白菊内酯通过激活HIPPO通路对代谢功能障碍相关性脂肪肝小鼠肝脏的保护作用

MOLECULAR MEDICINE REPORTS

IF3.5

2021-04-299

OAAI

AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradation

NATURE COMMUNICATIONS

IF15.7

2020-10-1284

OAAI

Selecting clinical lead of TCRs targeting alpha-fetoprotein-positive liver cancer on balance of risk and benefit

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-04-2719

OAAI

Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-04-2730

OAAI

Engineering T cells for immunotherapy of primary human hepatocellular carcinoma

JOURNAL OF GENETICS AND GENOMICS

IF7.1

2020-01-0114

OAAI

Establishment and evaluation of a model for predicting 3-month mortality in Chinese patients with hepatic encephalopathy

METABOLIC BRAIN DISEASE

IF3.5

2018-11-157

PREAI

Harnessing the CD8+T-cell subsets with stemness for tumor immunotherapy

利用具有干细胞性的CD8 T细胞亚群进行肿瘤免疫治疗

FUTURE ONCOLOGY

IF2.6

2018-08-241

OAAI

Identification of -fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy

IF15.8

2018-06-1296

OAAI

CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy

CK1α 通过稳定PTEN和诱导自噬抑制肺肿瘤生长

NATURE CELL BIOLOGY

IF19.1

2018-03-28107

PREAI